Warner Biddle is the Chief Executive Officer of Kyverna Therapeutics, bringing over 30 years of global experience in senior commercial and franchise leadership roles across a wide range of disease areas, products, and geographies. Mr. Biddle holds an Honors Degree in Commerce from the University of Saskatchewan, with a specialization in Marketing and Statistics. Prior to joining Kyverna, Mr. Biddle served as Senior Vice President, Global Head of Commercial at Kite Pharma (a Gilead Company), where he led multiple product launches and market building initiatives, driving unprecedented growth for Yescarta® and Tecartus® that established Kite as the world leader in the cell therapy market. Prior to joining Kite, Mr. Biddle spent a decade at Genentech, where he successfully led the Breast/Gynecology, Skin Cancer and Ophthalmology franchises through multiple launches and line extensions, including Kadcyla®, Tecentriq®, Erivedge® and Lucentis®. Mr. Biddle also held senior commercial and franchise leadership roles at Novartis and GlaxoSmithKline (GSK) working in Canada, the United Kingdom and Switzerland.